RPS6 and neoplasm: By contrast, although temsirolimus treatment (20 mg/kg i.p. twice a week) (39) led to dephosphorylation of RPS6, it only induced regression in 1 of 8 tumors (–10% volume) and had no effect on tumor growth in 1 of the 2 models tested (Supplemental Figure 9).